Milestone Scientific (NYSE:MLSS) Earns Hold Rating from Analysts at StockNews.com

StockNews.com assumed coverage on shares of Milestone Scientific (NYSE:MLSS) in a research note published on Thursday morning. The firm issued a hold rating on the stock.

Milestone Scientific Stock Down 6.6 %

Shares of NYSE:MLSS opened at $0.65 on Thursday. Milestone Scientific has a fifty-two week low of $0.52 and a fifty-two week high of $1.35. The firm’s 50 day moving average price is $0.65 and its 200 day moving average price is $0.69. The stock has a market cap of $49.79 million, a price-to-earnings ratio of -6.50 and a beta of 0.94.

Milestone Scientific (NYSE:MLSS) last announced its quarterly earnings data on Friday, March 29th. The company reported ($0.03) EPS for the quarter. The firm had revenue of $2.26 million during the quarter. Milestone Scientific had a negative net margin of 70.50% and a negative return on equity of 86.72%.

Institutional Inflows and Outflows

An institutional investor recently bought a new position in Milestone Scientific stock. AE Wealth Management LLC acquired a new position in shares of Milestone Scientific Inc. (NYSE:MLSS) during the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm acquired 27,936 shares of the company’s stock, valued at approximately $26,000. 5.79% of the stock is currently owned by institutional investors and hedge funds.

About Milestone Scientific

Milestone Scientific Inc, a biomedical technology research and development company, patents, designs, develops, and commercializes diagnostic and therapeutic injection technologies, and devices for medical, dental, and cosmetic use in the United States, China, and internationally. The company operates through Dental and Medical segments.